Formula & Concentration

Antihemophilic Factor (Recombinant)

Manufacturer

Takeda

Indications

RECOMBINATE is indicated in hemophilia A (classical hemophilia) for the prevention and control of hemorrhagic episodes and for the perioperative management of patients with hemophilia A. RECOMBINATE is not indicated for von Willebrand’s disease.

Product Options

Vial Size NDC Manufacturer # Size
220-400 IU 0944-2831-10 501592 10ml w/ Baxjet II Device
401-800 IU 0944-2832-10 1501593 10ml w/ Baxjet II Device
801-1240 IU 0944-2833-10 1501594 10ml w/ Baxjet II Device
1241-1800 IU 0944-2834-10 1502946 10ml w/ Baxjet II Device
1801-2400 IU 0944-2835-10 1502947 10ml w/ Baxjet II Device
220-400 IU 0944-2841-10 1502735 5ml w/ Baxjet II Device
401-800 IU 0944-2842-10 1502736 5ml w/ Baxjet II Device
801-1240 IU 0944-2843-10 1502737 5ml w/ Baxjet II Device
1241-1800 IU 0944-2844-10 1503132 5ml w/ Baxjet II Device
1801-2400 IU 0944-2845-10 1503133 5ml w/ Baxjet II Device

Shelf Life & Storage

36 Months / Refrigeration 2° – 8°C (36° – 46°F) or room temperature, not to exceed 30°C or 86°F until expiration date noted on package.

See full prescribing information for Recombinate supplied with 5mL diluent

See full prescribing information for Recombinate supplied with 10mL diluent
 

Recombinate

To order, call

855-307-6880

or fax
602-850-6226
or email
canyoncarerx@canyoncarerx.com

Can't find what you are looking for?

Please call us and we would love to help.

855-307-6880